Smoking Cessation: Clinical Trials

5 trials for Smoking Cessation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 withdrawn. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Withdrawn 5

Follow Smoking Cessation: new trials by email Literature Review of Smoking Cessation trials Research Report on Smoking Cessation

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study Protocol
High-intensity smoking cessation intervention, Low-intensity smoking cessation intervention - Chronic Obstructive Pulmonary Disease, Smoking Cessation
Phase 4WithdrawnPradeesh Sivapalan2023-07-012023-02-23
Mobile Health Interventions for Medication Adherence Among PLWH
Varenicline, Mobile phone application, Contingency management - HIV/AIDS, Smoking
Phase 4WithdrawnDuke University2021-11-012021-09-05
Opioids and Smoking Cessation
Nicotine patch - Smoking, Smoking Cessation
Phase 4WithdrawnUniversity of Houston2020-12-012022-05-20
Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
Varenicline - Schizophrenia, Schizoaffective
Phase 4WithdrawnUniversity of British Columbia2008-04-012017-11-29
Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal
varenicline, Adaptation of Motivational Interviewing - Tobacco Use Disorder
Phase 4WithdrawnVA Boston Healthcare System2015-06-04

Narrower conditions

Smoking (3)  ·  Schizophrenia (2)  ·  Tobacco Use Disorder (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Lung Diseases, Obstructive (1)  ·  Opioid-Related Disorders (1)  ·  Psychotic Disorders (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Tobacco Smoking (1)

Broader conditions

Behavior (5)  ·  Health Behavior (5)  ·  Chemically-Induced Disorders (3)  ·  Mental Disorders (3)  ·  Substance-Related Disorders (3)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (2)  ·  Blood-Borne Infections (1)  ·  Chronic Disease (1)  ·  Communicable Diseases (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)

Interventions

Varenicline (3)  ·  Nicotine Replacement Therapy (1)  ·  Tobacco Use Cessation Devices (1)

Sponsors

Duke University (1)  ·  Pradeesh Sivapalan (1)  ·  University of British Columbia (1)  ·  University of Houston (1)  ·  VA Boston Healthcare System (1)

Countries

United States (2)  ·  Denmark (1)

Top investigators

Alasdair Barr, Ph.D (1)  ·  Andrew H Rogers, M.A. (1)  ·  Barbara W Kamholz, Ph.D. (1)  ·  Chris Schenk, MD (1)  ·  Gary B Kaplan, M.D. (1)  ·  James Levitt, M.D. (1)  ·  Jens-Ulrik S Jensen, MD, PhD (1)  ·  Joyce Coutts, MD (1)  ·  Lauren R Pacek, PhD (1)  ·  Ric M. Procyshyn, Ph.D (1)  ·  Sean Flynn, MD (1)  ·  Suzy Bird Gulliver, Ph.D. (1)  ·  William Honer, MD (1)

Results publications

PMID 11377644, PMID 15539711, PMID 15955146, PMID 16899830, PMID 18569763, PMID 19194768, PMID 19357145, PMID 19801582, PMID 20335292, PMID 20843247, PMID 21621992, PMID 23649439, PMID 24524926, PMID 24729698, PMID 25176970, PMID 25253795, PMID 26362660, PMID 26414484, PMID 26964078, PMID 27545342, PMID 29377409, PMID 31166007, PMID 32825845, PMID 34611902

NIH funding

K01DA043413 (1)